Loading...
Chemical structure of Fuzapladib

GC71535

Fuzapladib

Also known as N-[2-(ethylsulfonylamino)-5-(trifluoromethyl)-3-pyridinyl]cyclohexanecarboxamide

Fuzapladib (IS-741), an orally active leukocyte-function-associated antigen type 1 (LFA-1) activation inhibitor, is a leukocyte adhesion molecule

ChemicalCAS141283-87-6MW379.4FormulaC15H20F3N3O3S
CAS number
141283-87-6
Molecular weight
379.4
Formula
C15H20F3N3O3S
Solubility
DMSO ： 100 mg/mL (263·57 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
InChIKey
TUWCZRFHNIOVTC-UHFFFAOYSA-N
Catalogue number
GC71535
Brand
GLPBIO
Computed properties PubChem CID 154529 · XLogP 2.7 · TPSA 96.5 Ų · H-bond donors 2
XLogP
2.7
TPSA
96.5 Ų
H-bond donors
2
H-bond acceptors
8
Rotatable bonds
5
Heavy atoms
25

SMILES CCS(=O)(=O)NC1=C(C=C(C=N1)C(F)(F)F)NC(=O)C2CCCCC2

Computed descriptors from PubChem (CID 154529), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.